Mycamine from Astellas Pharma was given a supplemental indication approval
Women with Delayed Menopause May Face Increased Risk of Asthma
Women experiencing later menopause may face a heightened risk of asthma, underscoring the possible role of estrogen in the development of the condition.
Keeping the Focus on Community Pharmacy Advocacy at the State Level
Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
Risk of Parkinson Disease Increases With Gastrointestinal Mucosal Damage
Researchers addressed the gut-first hypothesis of Parkinson disease by identifying how mucosal damage impacts risk of development.
How Pharmacy Advocacy is Heating Up at the Federal Level
Drug Topics discussed independent pharmacy advocacy and PBM reform on the federal level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
Best Practices for Proactively Preventing PBM Audit Issues | NCPA 2024
Trent Thiede, PharmD, MBA, president of PAAS National, discusses best practices that pharmacy teams can implement to proactively prevent audit issues before they arise.
Leveraging US Prescription Market Insights to Drive Pharmacy Innovation
Scott Biggs, Director of Supplier Services at IQVIA, discussed pharmacy trends within the industry and how pharmacists can stay ahead of them.
